Apolipoprotein E isoforms and susceptibility to genetic generalized epilepsies
João Chaves1,2, Ricardo Martins-Ferreira1,3, Cláudia Carvalho1,3
1Unidade Multidisciplinar de Investigação Biomédica, Instituto Ciências Biomédicas Abel Salazar, Universidade do Porto (UMIB/ICBAS-UP), Porto, Portugal.
The ApoE e3/e2 genotype appears to protect against Genetic Generalized Epilepsies (GGE). This finding suggests Apolipoprotein E (ApoE) isoforms play a role in epilepsy development, potentially through neuroprotective mechanisms.
Area of Science:
- Neuroscience
- Genetics
- Epilepsy Research
Background:
- Apolipoprotein E (ApoE) is crucial for brain repair and immune function.
- The ApoE e4 isoform is linked to epilepsy, but its role in Genetic Generalized Epilepsies (GGE) is unclear.
- Understanding ApoE's role in GGE is vital for epilepsy research.
Purpose of the Study:
- To investigate if Apolipoprotein E (ApoE) isoforms are risk factors for Genetic Generalized Epilepsies (GGE).
Main Methods:
- A case-control genetic association study compared 337 GGE patients with 342 healthy individuals.
- Apolipoprotein E (ApoE) genotyping was performed using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP).
Main Results:
- The ApoE e3/e2 genotype frequency was significantly lower in GGE patients (6.5%) compared to controls (11.7%).
- This suggests the ApoE e3/e2 genotype may be a protective factor against GGE development.
- No associations were found between ApoE isoforms and photosensitivity or age at disease onset.
Conclusions:
- The ApoE e3/e2 genotype may confer neuroprotection, potentially preventing oxidative damage and promoting neuronal survival in GGE.
- Apolipoprotein E (ApoE) isoforms appear to influence epileptogenic mechanisms across different epilepsy types.
- Further replication studies are needed to confirm these findings regarding ApoE and GGE.
More Related Videos
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Glutamate Antagonists
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
